And there you have the nail in the coffin. AZZ are out of cash this quarter and can't even pay the $1.1M interest due on notes this quarter let alone the $23.8M on note redemption. @IFINO how did the dreaming work out for you?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%